➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Medtronic
Harvard Business School
McKesson
Mallinckrodt

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Ferric derisomaltose - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ferric derisomaltose and what is the scope of patent protection?

Ferric derisomaltose is the generic ingredient in one branded drug marketed by Pharmacosmos As and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric derisomaltose has thirty-one patent family members in twenty-five countries.

There are twenty drug master file entries for ferric derisomaltose.

Summary for ferric derisomaltose
International Patents:31
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 20
Clinical Trials: 1
DailyMed Link:ferric derisomaltose at DailyMed
Recent Clinical Trials for ferric derisomaltose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Saarland UniversityPhase 4

See all ferric derisomaltose clinical trials

US Patents and Regulatory Information for ferric derisomaltose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-003 Jan 16, 2020 RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-001 Jan 16, 2020 DISCN Yes No   Start Trial   Start Trial Y Y   Start Trial
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-001 Jan 16, 2020 DISCN Yes No   Start Trial   Start Trial Y Y   Start Trial
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Baxter
AstraZeneca
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.